Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Medtronic
McKesson
Express Scripts
Dow

Last Updated: December 3, 2022

CLINICAL TRIALS PROFILE FOR DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Dapagliflozin; Metformin Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00528879 ↗ A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone Completed Bristol-Myers Squibb Phase 3 2007-09-01 The purpose of this clinical research study is to learn whether dapagliflozin can help reduce blood sugar levels in participants with Type 2 diabetes that is not well controlled on metformin alone. The safety of this treatment will also be studied.
NCT00528879 ↗ A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone Completed AstraZeneca Phase 3 2007-09-01 The purpose of this clinical research study is to learn whether dapagliflozin can help reduce blood sugar levels in participants with Type 2 diabetes that is not well controlled on metformin alone. The safety of this treatment will also be studied.
NCT00546741 ↗ Drug Interaction With Metformin Completed Bristol-Myers Squibb Phase 1 2007-11-01 The purpose of the study is to determine the effect of metformin on dapagliflozin exposure and the effect of dapagliflozin on metformin exposure in healthy volunteers. Additionally, the safety and tolerability of dapagliflozin will be assessed in the presence and absence of metformin in healthy volunteers
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Dapagliflozin; Metformin Hydrochloride

Condition Name

Condition Name for Dapagliflozin; Metformin Hydrochloride
Intervention Trials
Type 2 Diabetes 20
Type 2 Diabetes Mellitus 20
Diabetes Mellitus, Type 2 17
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Dapagliflozin; Metformin Hydrochloride
Intervention Trials
Diabetes Mellitus, Type 2 69
Diabetes Mellitus 68
Glucose Intolerance 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Dapagliflozin; Metformin Hydrochloride

Trials by Country

Trials by Country for Dapagliflozin; Metformin Hydrochloride
Location Trials
United States 281
Mexico 43
Canada 36
Korea, Republic of 26
United Kingdom 22
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Dapagliflozin; Metformin Hydrochloride
Location Trials
Texas 21
Florida 16
California 15
South Carolina 12
Ohio 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Dapagliflozin; Metformin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Dapagliflozin; Metformin Hydrochloride
Clinical Trial Phase Trials
Phase 4 34
Phase 3 34
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Dapagliflozin; Metformin Hydrochloride
Clinical Trial Phase Trials
Completed 54
Recruiting 18
Unknown status 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Dapagliflozin; Metformin Hydrochloride

Sponsor Name

Sponsor Name for Dapagliflozin; Metformin Hydrochloride
Sponsor Trials
AstraZeneca 51
Bristol-Myers Squibb 12
The University of Texas Health Science Center at San Antonio 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Dapagliflozin; Metformin Hydrochloride
Sponsor Trials
Other 86
Industry 82
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
McKesson
Merck
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.